Shopping Cart
Remove All
Your shopping cart is currently empty
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $43 | - | In Stock | |
| 10 mg | $77 | - | In Stock | |
| 25 mg | $172 | - | In Stock | |
| 50 mg | $293 | - | In Stock | |
| 100 mg | $513 | - | In Stock | |
| 500 mg | $1,090 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $48 | - | In Stock |
| Description | BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases. |
| In vitro | BML-259 prevents a large population of cells from NAC-evoked cell death[1]. |
| Synonyms | CAY10554 |
| Molecular Weight | 260.35 |
| Formula | C14H16N2OS |
| Cas No. | 267654-00-2 |
| Smiles | CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO:PBS (pH 7.2)(1:2): 0.3 mg/mL (1.15 mM), Sonication is recommended. DMF: 30 mg/mL (115.23 mM), Sonication is recommended. DMSO: 120 mg/mL (460.92 mM), Sonication is recommended. Ethanol: 0.25 mg/mL (0.96 mM), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.